Immunity :: Immune police recognize good and bad guys in the body
Immune system police are as good at recognizing bad guys, such as bacteria and viruses, as they are our own tissue, researchers say.
Medical college
Epilepsy :: Implantable device designed to detect, stop seizures under study at MCG
A small device implanted in the skull that detects oncoming seizures, then delivers a brief electrical stimulus to the brain to stop them is under study at the Medical College of Georgia.
Lung :: Nuclear medicine approach can be first choice for excluding pulmonary embolism in young women
Young women at risk of having a pulmonary embolism?a potential life-threatening blockage in a lung artery?should first undergo a ventilation/perfusion lung scan (V/Q scan) rather than a CT (computed tomography) angiogram, conclude authors in a paper published in the September Journal of Nuclear Medicine.
Heart Disease :: Environmental stress probed in heart disease, diabetes
How environmental stress contributes to cardiovascular disease and type 2 diabetes is under study at the Medical College of Georgia. The study, which follows 523 pairs of twins, is funded by a $1.7 million continuation grant from the National Institutes of Health.
Hepatitis :: HCV and HBV spreading more slowly among injection drug users in San Francisco
Injection drug users are still at a very high risk of acquiring hepatitis C (HCV) and hepatitis B (HBV); however, needle-sharing is less common, and users do not become infected as quickly as they did in the past, according to a new study in the September issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD).
Sleep Apnea :: Jefferson specialists studying innovative surgery for effectively treating sleep apnea
Sleep disorder and ear, nose and throat specialists at Thomas Jefferson University are examining an innovative procedure to treat obstructive sleep apnea syndrome.
Alzheimer’s Disease :: Baxter & Alzheimer’s Disease Cooperative Study Group to pursue study of Gammagard Liquid
Baxter International Inc. (NYSE: BAX) and The Alzheimer?s Disease Cooperative Study (ADCS) group announced the decision to pursue a multi-center U.S. Phase III study evaluating the role of Gammagard Liquid [Immune Globulin Intravenous (Human)] (IGIV) , an intravenous immunoglobulin preparation, for the treatment of patients with mild to moderate Alzheimer?s disease.
Cancer :: New cancer fighter may help ICU patients beat infections
HSP 90 inhibitors, which are finding favor in fighting cancer, may also help battle overwhelming infection in intensive care patients, researchers say.
Macular Degeneration :: Age-related Macular Degeneration Patient Receives Investigational Eye Drops
An 88-year-old man at The Methodist Hospital in Houston is one of two patients in the world today to receive an investigational eye drop that may restore sight for those suffering from neovascular (wet) age-related macular degeneration, a major cause of central visual loss and one of the leading causes of blindness in people over 60 in the United States.
Skin :: Green tea holds promise as new treatment for inflammatory skin diseases
Green tea could hold promise as a new treatment for skin disorders such as psoriasis and dandruff, Medical College of Georgia researchers say.